Riskpilot← Back to searchSign inGet full accessCELL BIOTECH INTERNATIONAL A/S
A/SActiveCVR 34207283Sorgenfrivej 15Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20129 employees
Revenue 2025
DKK 8,7M
+24% vs 2024
EBITDA margin
26.2%
+51% vs 2024
Equity ratio
44.3%
Financial strength
Net profit 2025
DKK 2,1M
+47% vs 2024
| Revenue | DKK 8,7M | +24% |
| EBITDA | DKK 2,3M | +51% |
| Net profit | DKK 2,1M | +47% |
| Total assets | DKK 58,9M | +115% |
| Equity | DKK 26,1M | +63% |
| Employees | 9 | — |
Legal name
CELL BIOTECH INTERNATIONAL A/S
CVR number
34207283
Legal form
Aktieselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
1. januar 2012
Share capital
DKK 20.829.198
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af to medlemmer af bestyrelsen i forening.
Company purpose
Selskabets formål er salg og markedsføring af probiotika, kosmetik, kosttilskud og generelle fødevarer, køb af råvarer af probiotika, kosmetik, kosttilskud og generelle fødevarer,import og eksport af probiotika, kosmetik, kosttilskud og generelle fødevarer, import og eksport af råvarer af probiotika, kosmetik, kosttilskud og generelle fødevarer samt hermed beslægtede aktiviteter.
Address
Sorgenfrivej 15
Phone
+4539775040
Email
info@cellbiotechint.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6.870 | 7.094 | 8.248 | 7.032 | 8.717 |
| Staff expenses | -4.868 | -4.578 | -5.517 | -5.513 | -6.430 |
| EBITDA | 2.002 | 2.516 | 2.731 | 1.519 | 2.287 |
| Depreciation & amort. | -57 | -57 | -57 | -57 | -94 |
| EBIT | 1.945 | 2.459 | 2.674 | 1.462 | 2.194 |
| Net financials | -46 | -47 | -23 | -27 | 16 |
| Profit before tax | 1.899 | 2.411 | 2.651 | 1.434 | 2.210 |
| Tax | -0 | -0 | -0 | -0 | 97 |
| Net profit | 1.899 | 2.411 | 2.651 | 1.434 | 2.113 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 19.727 | 24.669 | 28.301 | 27.366 | 58.921 |
| Equity | 9.488 | 11.900 | 14.550 | 15.985 | 26.098 |
| Long-term debt | 436 | 118 | 0 | 0 | 0 |
| Short-term debt | 9.803 | 12.651 | 13.751 | 11.381 | 32.823 |
| Total debt | 10.239 | 12.770 | 13.751 | 11.381 | 32.823 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20212025
Equity ratio
44.3%
This company
38.2%
Market median
+16% vs market
20212025
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20212025
Net profit margin
24.2%
This company
8.1%
Market median
+199% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM Management | Management | 2012 |
| Former (1) | ||
PA Management | Management | 2012 – 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2012 | |
| Former (4) | ||
| Board of Directors | 2012 – 2025 | |
| Chairman | 2012 – 2012 | |
| Chairman | 2012 – 2012 | |
UL | Board of Directors | 2012 – 2012 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELL BIOTECH INTERNATIONAL A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Andreas Stakemann | Management | 0 companies |
| Chung Myung Jun | Management | 0 companies |
| Yoon Seong Bae | Board of Directors | 0 companies |
| Young Oak Yun | Chairman | 0 companies |
| Chung Yu Sook | Board of Directors | 0 companies |
| Thomas Jeffrey Malherbes Gullacksen | Chairman | 0 companies |
| Yun Young Oak | Chairman | 0 companies |
| Ulf Lund | Board of Directors | 0 companies |